Skip to main content

The Effect of Estrogens on Depression

  • Chapter
Estrogen Effects in Psychiatric Disorders

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abramowitz ES, Baker AH, Fleiscler S (1982) Onset of depressive psychiatric crisis and the menstrual cycle. Am J Psychiatry 139: 475–478

    PubMed  CAS  Google Scholar 

  • Angold A, Costello EJ, Erkanli A, Worthman CM (1999) Pubertal changes in hormone levels and depression in girls. Psychol Med 29: 1043–53

    Article  PubMed  CAS  Google Scholar 

  • Angold A, Costello EJ, Worthman CM (1998) Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med 28: 51–61

    Article  PubMed  CAS  Google Scholar 

  • Angst J, Frey R, Lohmeyer R, Zerben-Rubin E (1980) Bipolar manic depressive psychoses: results of a genetic investigation. Hum Genet 55: 237–254

    Article  PubMed  CAS  Google Scholar 

  • Appleby L, Gregoire A, Platz C (1994) Screening women for high risk postnatal depression. J Psychosom Res 38: 539–545

    Article  PubMed  CAS  Google Scholar 

  • Archer JS (1999) Relationship between estrogen, serotonin, and depression. Menopause 6: 71–78

    PubMed  CAS  Google Scholar 

  • Aylward M, Holly F, Parker RI (1974) An evaluation of clinical response to pipera-zineoestronesulphate ("Harmogen") in menopausal patients. Curr Med Res Opin: 417

    Google Scholar 

  • Backstrom T, Landgren S, Zetterland B (1984) Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure, variation during the menstrual cycle. In: Porter RJ, Mattson RH, Ward AAJ (eds) Advances in epileptology. Raven Press, New York, 269–277

    Google Scholar 

  • Birge S (1997) The role of estrogen in the treatment of Alzheimer’s disease. Neurology 48(Suppl 7): S36–S41

    PubMed  CAS  Google Scholar 

  • Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157: 924–930

    Article  PubMed  CAS  Google Scholar 

  • Brayshaw ND, Brayshaw DD (1986) Thyroid hypofunction in premenstrual syndrome. N Engl J Med 315: 1486

    PubMed  CAS  Google Scholar 

  • Brincat M, Studd JW, O'Dow W, Magos A, Cardozo LD, Wardle PJ (1984) Subcutaneous hormone implants for the control of climetric symptoms. Lancet: 160–168

    Google Scholar 

  • Brockington IF, Kelly A, Hall P (1988a) Premenstrual relapse puerperal psychosis. J Affect Disord 14: 287–292

    Article  PubMed  CAS  Google Scholar 

  • Brockington IF, Margison FR, Schofield EM, Knight RJE (1988b) The clinical picture of the depressed form of puerperal psychosis. J Affect Disord 15: 29–37

    Article  PubMed  CAS  Google Scholar 

  • Burvill PW (1995) Recent progress in the epidemiology of major depression. Epidemiol Rev 17: 21–31

    PubMed  CAS  Google Scholar 

  • Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obset Gynaecol 4: 31–47

    CAS  Google Scholar 

  • Campbell S (1976) Double blind psychometric studies on the effects of natural estrogens on post-menopausal women. In: Campbell S (ed) The management of menopause and postmenopausal years. MTP, Lancaster, 149–158

    Google Scholar 

  • Carothers AD, Murray L (1990) Estimating psychiatric morbidity by logistic regression: application to post-natal depression in a community sample. Psychol Med 20: 695–702

    PubMed  CAS  Google Scholar 

  • Casper RF, Patel-Christopher A, Powell A (1989) Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome. J Clin Endocrinol Metab 68: 608–612

    PubMed  CAS  Google Scholar 

  • Chakravorty SG, Halbreich U (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33: 229–233

    PubMed  CAS  Google Scholar 

  • Coope I (1981) Is oestrogen therapy effective in the treatment of menopausal depression. J R Coll Gen Pract 31: 134–140

    PubMed  CAS  Google Scholar 

  • Coope I (1981) The menopause. Is oestrogen therapy affective in the treatment of postmenopausal depression. J R Coll Gen Pract 31: 134–140

    PubMed  CAS  Google Scholar 

  • Coope J, J.M. T, Poller L (1975) Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. BMJ 4: 139–143

    Article  PubMed  CAS  Google Scholar 

  • Cooper PJ, Murray L, Hooper R, West A (1996) The development and validation of a predictive index for postpartum depression. Psychol Med 26: 627–634

    PubMed  CAS  Google Scholar 

  • Coppen A, Bishop M, Beard RJ (1977) Effects on piperazine oestrone sulphate on plasma tryptophan, oestrogens, gonadotrophins and psychological functioning in women following hysterectomy. Curr Med Res Opin 4: 29–36

    Google Scholar 

  • Cox JL, Connor Y, Kendell RE (1982) Prospective sudy of the psychiatric disorders of childbirth. Br J Psychiatry 140: 111–117

    PubMed  CAS  Google Scholar 

  • Dahr V, Murphy BEP (1990) Double-blind randomized crossover trial of luteal phase estrogens (Premarin®). Psychoneuroendrocrinology 15: 489–493

    Google Scholar 

  • Dalton K (1964) The premenstrual syndrome. Heinemann, London

    Google Scholar 

  • Demyttenaere K, Lenaerts H, Nijs P, Van Assche FA (1995) Individual coping style and psychological attitudes during pregnancy predict depression levels during pregnancy and during postpartum. Acta Psychiatr Scand 91: 95–102

    PubMed  CAS  Google Scholar 

  • Dennerstein L, Burrows GD (1979) Affect and the menstrual cycle. J Affect Disord 1: 77–92

    Article  PubMed  CAS  Google Scholar 

  • Derman RJ, Dawood MY, Stone S (1995) Quality of life during sequential hormone replacement therapy — a placebo-controlled study. Int J Fertil Menopausal Stud 40: 73–78

    PubMed  CAS  Google Scholar 

  • Dickinson SL, Curzon G (1986) 5-Hydroxytryptamine-mediated behavior in male and female rats. Neuropharmacology 25: 771–776

    Article  PubMed  CAS  Google Scholar 

  • Ditkoff EC, Crary WG, Cristo M, Lobo R (1991) Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78: 991–995

    PubMed  CAS  Google Scholar 

  • d'Orban PT, Dalton J (1980) Violent crime and the menstrual cycle. Psychol Med 10: 353–359

    Article  PubMed  Google Scholar 

  • Endicott J, Halbreich U (1988) Clinical significance of premenstrual dysphoric changes. J Clin Psychiatry 49: 486–489

    PubMed  CAS  Google Scholar 

  • Epperson CN, Wisner KL, Yamamoto B (1999) Gonadal steroids in the treatment of mood disorders. Psychosom Med 61: 676–697

    PubMed  CAS  Google Scholar 

  • Fedor-Freybergh (1977) The influence on oestrogen on wellbeing and mental performance in climacteric postmenopausal women. Acta Obstet Gynecol Scand 64: 2–10

    Google Scholar 

  • Frank R (1931) The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26: 1053–1057

    Google Scholar 

  • Freeman E, Rickels K, Sondheimer SJ, Polansky M (1990) Ineffectiveness of progesterone suppository treatment for premenstrual syndrome: a placebo-controlled, randomized, double-blind study. JAMA 264: 349–353

    Article  PubMed  CAS  Google Scholar 

  • Freeman EW, Sondheimer SJ, Rickels K, Weinbaum PJ (1985) PMS treatment approaches and progesterone therapy. Psychosomatics 26: 811–816

    PubMed  CAS  Google Scholar 

  • Friedman RC, Hurt SW, Charkin J (1982) Sexual histories and premenstrual affective syndrome in psychiatric inpatients. Am J Psychiatry 139: 1484–1486

    PubMed  CAS  Google Scholar 

  • Furuhjelm M, Karlgren E, Carlstrom K (1984) The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 63: 655–661

    PubMed  CAS  Google Scholar 

  • Garlow SJ, Musselman DJ, Nemeroff CB (1999) The neurochemistry of mood disorders: clinical studies. In: Charney DS, Nestler EJ, Bunney BS (eds) Neurobiology of mental illness. Oxford University Press, New York

    Google Scholar 

  • George GCW, Utian WH, Beumont PJV, Bearwood CJ (1973) Effect of exogenous oestrogens on mionor psychiatric symptoms in postmenopausal women. S Afr Med J 47: 2387–2388

    PubMed  CAS  Google Scholar 

  • Gerdes LC, Sonnendecker EWW, Polakow ES (1979) Psychological changes effected by estrogen-progestogen and chlonidine treatment in climacteric women. Am J Obstet Gynecol 1: 77–92

    Google Scholar 

  • Gladis MM, Walsh BT (1987) Premenstrual exacerbation of binge eating in bulimia. Psychiatry 144: 1592–1595

    CAS  Google Scholar 

  • Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347: 930–3

    Article  PubMed  CAS  Google Scholar 

  • Gurguis GN, Yonkers KA, Blakeley JE, Phan SP, Williams A, Rush AJ (1998a) Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res 79: 31–42

    Article  PubMed  CAS  Google Scholar 

  • Gurguis GN, Yonkers KA, Phan SP, Blakeley JE, Williams A, Rush AJ (1998b) Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biol Psychiatry 44: 600–609

    Article  PubMed  CAS  Google Scholar 

  • Halbreich U, Alt IH, Paul L (1988) Premenstrual changes. Impaired hormonal homeostasis. Neurol Clin 6: 173–94

    PubMed  CAS  Google Scholar 

  • Halbreich U, Ben-David M, Assael M, Bornstein R (1976) Serum-prolactin in women with premenstrual syndrome. Lancet 02: 654–656

    CAS  Google Scholar 

  • Halbreich U, Carson S, Rojansky N, Lane J, Alt E (1988) 20% of women who reported premenstrual dysphoric changes might have subclinical hypothyroidism. Proc Annual Meeting of the American College of Neuropsychopharmacology (ACNP). San Juan, PR

    Google Scholar 

  • Halbreich U, Endicott J, Goldstein S, Nee J (1986) Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74: 576–586

    PubMed  CAS  Google Scholar 

  • Halbreich U, Endicott J, Schacht S, Nee J (1982) The diversity of premenstrual changes as reflected in the premenstrual assessment form. Acta Psychiatr Scand 65: 46–65

    PubMed  CAS  Google Scholar 

  • Halbreich U, Endicott J (1985) Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 71: 331–338

    PubMed  CAS  Google Scholar 

  • Halbreich U, Lumley LA (1993) The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 29: 159–173

    Article  PubMed  CAS  Google Scholar 

  • Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N (1993) Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premen-strual syndromes. Biol Psychiatry 34: 676–686

    Article  PubMed  CAS  Google Scholar 

  • Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434–441

    PubMed  CAS  Google Scholar 

  • Halbreich U, Rojansky N, Palter S (1991) Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 56: 1066–1069

    PubMed  CAS  Google Scholar 

  • Halbreich U, Smoller JW (1997) Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 58: 399–402

    PubMed  CAS  Google Scholar 

  • Halbreich U, Tworek H (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med 23: 1–27

    PubMed  CAS  Google Scholar 

  • Halbreich U (2000) Gonadal hormones, reproductive age, and women with depression. Arch Gen Psychiatry 57: 1163–1164

    PubMed  CAS  Google Scholar 

  • Halbreich U (1995) Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol 9: 163–175

    PubMed  CAS  Google Scholar 

  • Halbreich U (1997a) Menstrually related disorders — towards interdisciplinary international diagnostic criteria. Cephalalgia 17(Suppl 20): 1–4

    PubMed  Google Scholar 

  • Halbreich U (1997b) Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 95: 169–176

    PubMed  CAS  Google Scholar 

  • Halbreich U (1996) Premenstrual Syndromes. In: Halbreich U (ed) Balliere’s clinical psychiatry: International practice and research. Bailliere Tindall, London, 667–686

    Google Scholar 

  • Halbreich U (1997c) Psychiatric disorders in women. In: Weller M, van Kammen D (eds) Progress in clinical psychiatry. Saunders, London, 96–115

    Google Scholar 

  • Halbreich U (1997d) Role of estrogen in postmenopausal depression. Neurology 48: S16–19

    PubMed  CAS  Google Scholar 

  • Halbreich U (1999) RU-486, estrogen and leuprolide as treatment for PMS [abstract]. 30th Annual Meeting, ISPNE, Orlando, Florida

    Google Scholar 

  • Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications: Part II: Effects on selected psychotropics. In: Jensvold M, Halbreich U, Hamilton JA (eds) Psychopharmacology of women: sex, gender, and hormonal considerations. American Psychiatric Press, Washington DC, 43–71

    Google Scholar 

  • Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications: Part I: Physiological basis for effects. In: Jensvold M, Halbreich U, Hamilton JA (eds) Psychopharmacology of women: sex, gender, and hormonal considerations. American Psychiatric Press, Washington DC, 11–41

    Google Scholar 

  • Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG (1989) Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 30: 405–411

    PubMed  CAS  Google Scholar 

  • Hatotani N, Nishikubo M, Iitayama I (1979) Periodic psychosis in the female and the reproductive process. In: Zichella L, Pancheri P (eds) Psychoneuroendocrinology in reproduction. Elsevier North Holland, New York, 55–68

    Google Scholar 

  • Hurt SW, Schnurr PP, Severino SK, et al. (1992) Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 149: 525–530

    PubMed  CAS  Google Scholar 

  • Jensvold MF, Hamilton JA (1996) Sex and gender effects in psychopharmacology: contributory factors and implications for pharmacotherapy. In: Halbreich U (ed) Psychiatric issues in women. Bailliere Tindall, London, 647–665

    Google Scholar 

  • Jensvold MF (1996) Nonpregnant reproductive-age women, Part I: the menstrual cycle and psychopharmacology. In: Jensvold MF, Halbreich UH, Hamilton JA (eds) Psychopharmacology and women. American Psychiatric Press, Washington DC, 139–169

    Google Scholar 

  • Johnson SR (1987) The epidemiology and social impact of premenstrual symptoms. Clin Obstet 30: 369–384

    Google Scholar 

  • Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996) The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53: 391–399

    PubMed  CAS  Google Scholar 

  • Kessler R (2000) Gender and mood disorders. In: Goldman MB, Hatch MC (eds) Women and health. Academic Press, San Diego, 989–996

    Google Scholar 

  • Kessler RC, McGonagle KA, Zhao S, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8–19

    PubMed  CAS  Google Scholar 

  • Kessler RC, Walters EE (1998) Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7: 3–14

    Article  PubMed  CAS  Google Scholar 

  • Kessler RC (1995) Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohan M, Zahner GEP (eds) Textbook in psychiatric epidemiology. Wiley, New York, 179–197

    Google Scholar 

  • Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36: 550–554

    PubMed  CAS  Google Scholar 

  • Komstein SG, McEnany G (2000) Enhancing pharmacologic effects in the treatment of depression in women. J Clin Psychiatry 61(Suppl 11): 18–27

    Google Scholar 

  • Komstein SG, Schatzberg AF, Thase ME, et al. (2000) Gender differences in chronic major and double depression. J Affect Disord 60: 1–11

    Google Scholar 

  • Komstein SG, Schatzberg AF, Thase ME, et al. (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157: 1445–1452

    Google Scholar 

  • Komstein SG, Schatzberg AF, Yonkers KA, et al. (1995) Gender differences in presentation of chronic major depression. Psychopharmacol Bull 31: 711–718

    Google Scholar 

  • Komstein SG (1997) Gender differences in depression: implications for treatment. J Clin Psychiatry 58(Suppl 15): 12–18

    Google Scholar 

  • Kouri E, Halbreich U (1998) Psychotrophic effects of hormonal replacement therapy. Drugs of Today 34: 251–257

    PubMed  CAS  Google Scholar 

  • Kumar R, Robson KM (1984) A prospective study of emotional disorders in childbearing women. Br J Psychiatry 144: 35–47

    Article  PubMed  CAS  Google Scholar 

  • Leibenluft E, Hardin TA (1995) Gender differences in seasonal affective disorder. Depression 3: 13–19

    Google Scholar 

  • LeMeledo JM, Bradwein J, Koszycki D, Bichet D (1995) Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry 52: 605–606

    Google Scholar 

  • Lepage P, Steiner M (1991) Gender and serotonergic deregulation: implications for late luteal phase dysphoric disorder. In: Cassano GB, Akiskal HS (eds) Serotonin related psychiatric syndromes: Clinical and therapeutic links. Roy Soc Med Service Congress Symp Series No 165, London

    Google Scholar 

  • Lewinsohn PM, Rohde P, Seeley JR (1998) Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 18: 765–794

    PubMed  CAS  Google Scholar 

  • Luggin R, Bernsted L, Petersson B, Jacobsen AT (1984) Acute psychiatric admission related to the menstrual cycle. Acta Psychiatr Scand 69: 461–465

    PubMed  CAS  Google Scholar 

  • Luine VN (1985) Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89: 484–490

    Article  PubMed  CAS  Google Scholar 

  • Magos AL, Brincat M, Studd JWW (1986) Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: Placebo controlled study. BMJ 292: 1629–1633

    PubMed  CAS  Google Scholar 

  • Maoz B, Durst N (1980) The effects of oestrogen therapy on the sex life of postmenopausal women. Maturitas 2: 327–336

    PubMed  CAS  Google Scholar 

  • Matsumoto A, Arai Y, Osanai M (1985) Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 2: 412–418

    Article  PubMed  CAS  Google Scholar 

  • McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically-relevant basic sciences studies of gender differences and sex hormones effects. Psychopharmacol Bull 34: 251–259

    PubMed  CAS  Google Scholar 

  • McEwen BS, Alves SE, Bulloch K (1997) Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48(Suppl 7): S8–S15

    PubMed  CAS  Google Scholar 

  • McEwen BS, Woolley CS (1994) Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 29: 431–436

    Article  PubMed  CAS  Google Scholar 

  • McEwen BS (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12: 141–147

    Article  PubMed  CAS  Google Scholar 

  • Merikangas KR, Foeldenyl M, Angst J (1993) The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243: 23–32

    PubMed  CAS  Google Scholar 

  • Michael C, Kantor H, Shore H (1970) Further psychometric evaluation of older women — the effect of estrogen administration. J Gerontol 25: 337–341

    PubMed  CAS  Google Scholar 

  • Montgomery JC, Appleby L, Brincat M, et al. (1987) Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1: 297–299

    PubMed  CAS  Google Scholar 

  • Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Global burden of disease and injury series. The Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, Boston, 43

    Google Scholar 

  • Muse K, Cetel N, Futterman L, Yen SC (1984) The premenstrual syndrome: effects of ‘medical ovariectomy’. N Eng J Med 311: 1345–1349

    Article  CAS  Google Scholar 

  • O'Hara MW, Swain AM (1996) Rates and risk of postpartum depression — a meta-analysis. Int Rev Psychiatry 8: 37–54

    Article  Google Scholar 

  • O'Hara MW, Zekoski EM, Philipps LH, Wright EJ (1990) Controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchild-bearing women. J Abnorm Psychol 99: 3–15

    Article  PubMed  Google Scholar 

  • Ohayon MM, Caulet M (1995) Insomnia and psychotropic drug consumption. Progr Neuropsychopharmacol Biol Psychiatry 19: 421–431

    CAS  Google Scholar 

  • Ohkura T, Teshima Y, Isse K (1994) Estrogen increases cerebral and cerebellar blood flow in postmenopausal women. Menopause 2: 13–18

    Google Scholar 

  • Palinkas LA, Barrett-Connor E (1992) Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 80: 30–36

    PubMed  CAS  Google Scholar 

  • Parry BL (1989) Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 12: 207–220

    PubMed  CAS  Google Scholar 

  • Paterson MEL (1982) A randomized double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climateric symptoms and biochemical parameters. Maturitas 4: 83–94

    Article  PubMed  CAS  Google Scholar 

  • Piletz JE, Halbreich U (2000) Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry 48: 932–939

    PubMed  CAS  Google Scholar 

  • Prange AJ (1972) Estrogen may well affect response to antidepressant. JAMA 219: 143–144

    Google Scholar 

  • Price RA, Kidd KK, Weissman MM (1987) Early onset (under age 30 years) and panic disorder as markers etiologic homogeneity in major depression. Arch Gen Psychiatry 44: 434–440

    PubMed  CAS  Google Scholar 

  • Ramcharan S, Love EJ, Fick GH, Goldfien A (1992) The epidemiology of premen-strual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol 45: 377–392

    Article  PubMed  CAS  Google Scholar 

  • Rawson NSB, D'Arcy C (1991) Sedative hypnotic drug use in Canada. Health Reports 3: 33–57

    PubMed  CAS  Google Scholar 

  • Reighard FT, Evans ML (1995) Use of the Edinburgh Postnatal Depression Scale in a Southern, rural population in the United States. Progr Neuropsychophamacol Biol Psychiatry 19: 1219–1224

    CAS  Google Scholar 

  • Rivera-Tovar AD, Frank E (1990) Late luteal phase dysphoric disorder in young women. Am J Psychiatry 147: 1634–1636

    PubMed  CAS  Google Scholar 

  • Roy A, Gang P, Cole K, Rutsky M, Reese L, Weisbord J (1993) Use of Edinburgh Postnatal Depression Scale in a North American population. Progr Neuropsy-chophamacol Biol Psychiatry 17: 501–504

    CAS  Google Scholar 

  • Roy-Byrne PP, Rubinow DR, Hoban MC, Grover GN, Blank D (1987) TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 144: 480

    PubMed  CAS  Google Scholar 

  • Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44: 839–50

    Article  PubMed  CAS  Google Scholar 

  • Rubinow DR, Schmidt PJ, Roca CA (1998) Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. Psychopharmacol Bull 34: 289–290

    PubMed  CAS  Google Scholar 

  • Saletu B, Brandstatter N, Metkam M, et al. (1995) Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with trandermal oestradiol therapy in menopasual depression. Psychophamacology 122: 321–329

    Article  CAS  Google Scholar 

  • Sandberg D, Endicott J, Harrison W, Nee J, Gorman J (1993) Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatr Res 46: 79–88

    Article  CAS  Google Scholar 

  • Schmidt PJ, Nieman L, Danaceau MA, et al. (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183: 414–420

    Article  PubMed  CAS  Google Scholar 

  • Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338: 209–216

    Article  PubMed  CAS  Google Scholar 

  • Schmidt PJ, Roca CA, Bloch M, Rubinow DR (1997) The perimenopause and affective disorders. Semin Reprod Endocrinol 15: 91–100

    PubMed  CAS  Google Scholar 

  • Schneider LS, Small G, Clary C (1998) Estrogen replacement therapy and antidepressant response to sertraline [abstract]. Annual Meeting of the American Psychiatric Association, Toronto, Ontario

    Google Scholar 

  • Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5: 97–106

    PubMed  CAS  Google Scholar 

  • Schneider MA, Brotherton PL, Hailes J (1977) The effect of exogenous oestrogens on depression in menopausal women. Med J Aus 2: 162–163

    CAS  Google Scholar 

  • Seeman MV (2000) Mental illness in women. In: Goldman MB, Hatch MC (eds) Women and health. Academic Press, San Diego, 989–996

    Google Scholar 

  • Shapira B, Oppenheim G, Zohar J, Segal M, Malach D, Belmaker RH (1985) Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 20: 576–579

    Article  PubMed  CAS  Google Scholar 

  • Sherwin BB, Gelfand MM, Brender W (1985) Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 47: 339–351

    PubMed  CAS  Google Scholar 

  • Sherwin BB, Gelfand MM (1985) Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendoctrinology 10(3): 325–335

    CAS  Google Scholar 

  • Simpkins JW, Singh M, Bishop J (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer’s disease. Neurobiol Aging 15: S195–S197

    PubMed  Google Scholar 

  • Singh M, Meyer EM, Simpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in Sprague-Dawley rats. Brain Res 644: 305–312

    Article  PubMed  CAS  Google Scholar 

  • Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and oestradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136: 2320–2324

    PubMed  CAS  Google Scholar 

  • Skegg DCG, Doll R, Perry J (1977) Use of medicines in general practice. Br Med J 1: 1561–1563

    Article  PubMed  CAS  Google Scholar 

  • Steiner M, Born L, Marton P (2000) Menarche and mood disorders in adolescence. In: Steiner M, Yonkers K, Eriksson E (eds) Mood disorders in women. Martin Dunitz, London, 247–268

    Google Scholar 

  • Steiner M, Steinberg S, Stewart D, et al. (1995) Fluoxetine in the treatment of premenstrual dysphoria. Canadian fluoxetine/premenstrual dysphoria collaborative studygroup. N Eng J Med 332: 1529–1534

    CAS  Google Scholar 

  • Steiner M, Wheadon D, Kreider M, Bushnell W (1993) Antidepressant response to paroxetine by gender (Abstract #462). Ann Meeting American Psychiatric Association, San Francisco

    Google Scholar 

  • Stewart DE, Boydell KM (1993) Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 23: 157–162

    PubMed  CAS  Google Scholar 

  • Strickler RC, Borth R, Cecutti A, et al. (1977) The role of oestrogen replacement in the climacteric syndrome. Psychol Med 7: 631–639

    PubMed  CAS  Google Scholar 

  • Studd JWW, Smith RNJ (1994) Estrogens and depression in women. Menopause 1: 3–7

    Google Scholar 

  • Stunkard AJ, Fernstrom MH, Price A, Frank E (1990) Direction of weight change in recurrent depression: consistency across episodes. Arch Gen Psych 47: 857–860

    CAS  Google Scholar 

  • Terry DJ, Mayocchi L, Hynes GJ (1996) Depressive symptomatology in new mothers: a stress and coping perspective. J Abnorm Psychol 105: 220–231

    Article  PubMed  CAS  Google Scholar 

  • Thompson J, Oswald I (1977) Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. BMJ 19: 1317–1319

    Google Scholar 

  • Troutman BR, Cutrona CE (1990) Nonpsychotic postpartum depression among adolescent mothers. J Abnorm Psychol 99: 69–78

    Article  PubMed  CAS  Google Scholar 

  • Van Valkingburg C, Akiskal HS, Puzantian V, Rosenthal T (1984) Anxious depression: clinical, family history, and naturalistic outcome — comparisons with panic and major depressive disorders. J Affect Disord 6: 67–82

    Google Scholar 

  • Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ (1989) Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 2: 730–732

    PubMed  CAS  Google Scholar 

  • Weissman MM, Bland RC, Canino GJ, et al. (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293–299

    PubMed  CAS  Google Scholar 

  • Weissman MM, Klerman GL (1977) Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34: 98–111

    PubMed  CAS  Google Scholar 

  • Weissman MM, Livingston BM, Leaf PJ (1991) Affective disorders. In: Robins LN, Regier DA (eds) Psychiatric disorders in America. Free Press, New York

    Google Scholar 

  • Weissman MM (1979) The myth of involutional melancholia. Jama 242: 742–744

    Article  PubMed  CAS  Google Scholar 

  • West ED, Dally PJ (1992) Effect of iproniazid in depressive syndromes. BJM 1: 1491–1494

    Google Scholar 

  • Whiffen VE (1002) Is postpartum depression a distinct diagnosis? Clin Psychol Rev 12: 485–508

    Google Scholar 

  • Whiffen VE (1988) Vulnerability of postpartum depression: a prospective multivariate study. J Abnorm Psychol 97: 467–474

    Article  PubMed  CAS  Google Scholar 

  • Wikander I, Sundblad C, Andersch B et al. (1998) Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 18: 390–398

    Article  PubMed  CAS  Google Scholar 

  • Wiklund I, Karlberg J, Mattson L (1993) Quality of life menopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controled study. Am J Obstet Gynecol 168: 824–830

    PubMed  CAS  Google Scholar 

  • Wolley CS, McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12: 2549–2554

    Google Scholar 

  • Woods NF, Most A, Dery GK (1982) Prevalence of perimenstrual symptoms. Am J Public Health 72: 1257–1264

    PubMed  CAS  Google Scholar 

  • Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T (1996) Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 32: 41–46

    PubMed  CAS  Google Scholar 

  • Yonkers KA, Kando JC, Cole JO, Blumenthal S (1992) Gender differences in pharma-cokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587–595

    PubMed  CAS  Google Scholar 

  • Yonkers KA, Kando JC, Hamilton JA, Halbreich U (2000) Gender differences in treatment of depression and anxiety. In: Halbreich U, Montgomery SA (eds) Pharmacotherapy for mood, anxiety, and cognitive disorders. American Psychiatric Press, Washington DC, 59–74

    Google Scholar 

  • Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB (1998) Is the course of panic disorder the same in women and men? Am J Psychiatry 155: 596–602

    PubMed  CAS  Google Scholar 

  • Yonkers KA (1998) Assessing unipolar mood disorders in women. Psychopharmacol Bull 34: 261–266

    PubMed  CAS  Google Scholar 

  • Young E, Korszun A (1998) Psychoneuroendocrinology of depression. Hypothalamic-pituitary-gonadal axis. Psychiatr Clin North America 21: 309–323

    CAS  Google Scholar 

  • Young EA, Midgley AR, Carlson NE, Brown MB (2000) Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 57: 1157–1162

    PubMed  CAS  Google Scholar 

  • Zelkowitz P, Milet TH (1995) Screening for post-partum depression in a community sample. Can J Psychiatry 40: 80–86

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag/Wien

About this chapter

Cite this chapter

Kahn, L.S., Halbreich, U. (2005). The Effect of Estrogens on Depression. In: Bergemann, N., Riecher-Rössler, A. (eds) Estrogen Effects in Psychiatric Disorders. Springer, Vienna. https://doi.org/10.1007/3-211-27063-9_7

Download citation

  • DOI: https://doi.org/10.1007/3-211-27063-9_7

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-40485-0

  • Online ISBN: 978-3-211-27063-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics